About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Ohio | 865 Studies

Clinical Trials Lung CancerOhio

Lung Cancer Clinical Trials in Ohio

Find 865 clinical trials for lung cancer near Ohio. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 261-280 of 865 trials

Active not recruitingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerThis phase I trial identifies the best dose, possible benefits and/or side effects of BAY 1895344 in combination with chemotherapy in treating patients with solid tumors or…NCT04491942·Sacramento, California and 7 others CompletedRamucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Non-Match Treatment Trial)This phase II Lung-MAP non-Match treatment trial studies how well ramucirumab and pembrolizumab work versus standard of care in treating patients with non-small cell lung cancer…NCT03971474·Mobile, Alabama and 888 others

PreviousPage 14 of 44Next

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00026156·Mobile, Alabama and 95 others

RecruitingAdjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmA randomized trial of adjuvant Pembrolizumab following surgical resection versus observation following surgical resection in patients with stage I non-small cell lung cancer…NCT04317534·Tampa, Florida and 12 others

CompletedStudy of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.This was a Phase II, multicenter, non-randomized, open-label study to assess the efficacy, safety, and tolerability of dabrafenib administered as a single agent and in combination…NCT01336634·Los Angeles, California and 49 others

CompletedPemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy, such as pemetrexed disodium, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from…NCT00268489·Anchorage, Alaska and 247 others

TerminatedFeasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung CarcinomaThis pilot clinical trial studies stereotactic body radiation therapy followed by combination chemotherapy in treating patients with non-small cell lung cancer.NCT02319889·Cleveland, Ohio

CompletedPemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung CancerBoth pemetrexed and cetuximab have single agent activity in NSCLC and non-overlapping toxicity profiles.NCT00216203·Galesburg, Illinois and 10 others

Active not recruitingA Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerCLN-081-001 is a Phase 1/2, open label, multi-center study of CLN-081 in patients with non-small cell lung cancer (NSCLC) harboring EGFR (epidermal growth factor receptor) exon 20…NCT04036682·Anaheim, California and 63 others

Active not recruitingTesting the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With ImmunotherapyThis phase II trial studies how well MLN4924 (pevonedistat), carboplatin, and paclitaxel work in treating patients with stage IIIB or IV non-small cell lung cancer.NCT03965689·Los Angeles, California and 9 others

TerminatedS0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung CancerThis randomized phase III trial studies carboplatin and paclitaxel to compare how well they work with or without bevacizumab and/or cetuximab in treating patients with stage IV or…NCT00946712·Anniston, Alabama and 797 others

TerminatedPhase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion MutationThis is a Phase 2, open-label, multi-center study to evaluate the efficacy and the safety/tolerability of poziotinib in seven participant cohorts for up to 603 previously treated…NCT03318939·Phoenix, Arizona and 62 others

TerminatedAdagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14)This study will evaluate safety, tolerability, drug levels, molecular effects and clinical activity of MRTX849 (adagrasib) in combination with BI 1701963 in patients with advanced…NCT04975256·St Louis, Missouri and 3 others

RecruitingOpen-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung CancerA first in human study to evaluate the safety and preliminary antitumor activity of BBO-8520, a KRAS G12C (ON and OFF) inhibitor, as a single agent and in combination with…NCT06343402·Birmingham, Alabama and 37 others

CompletedA Study of SEA-CD40 Given With Other Drugs in CancersThis trial is being done to see if an experimental drug (SEA-CD40) works when it's given with other cancer drugs to treat some types of cancer.NCT04993677·Springdale, Arkansas and 28 others

CompletedCisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung CancerThis randomized phase I/II trial studies the side effects and best dose of veliparib when given together with or without cisplatin and etoposide and to see how well they work in…NCT01642251·Loma Linda, California and 427 others

CompletedNon-small Cell Lung Cancer RegistryThis trial will evaluate two separate groups of patients with stage IIIB/IV non-small cell lung cancer.NCT00099541·Birmingham, Alabama and 100 others

RecruitingA Platform Study in Non-Small Cell Lung Cancer (NSCLC)The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard…NCT06996782·Phoenix, Arizona and 102 others

CompletedS9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002969·Mobile, Alabama and 84 others

UnknownA Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid TumorsFirst-in-human, Phase I/II, Multicenter, Open-Label Study of EMB-01 in Patients with Advanced/Metastatic Solid TumorsNCT03797391·Boston, Massachusetts and 4 others

Other Conditions in Ohio

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma